Chimerix Inc (CMRX)
1.045
+0.04
(+3.47%)
USD |
NASDAQ |
Mar 28, 10:56
Chimerix Total Return Level: 1.01 for March 27, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
March 27, 2024 | 1.01 |
March 26, 2024 | 0.99 |
March 25, 2024 | 0.9845 |
March 22, 2024 | 0.9998 |
March 21, 2024 | 0.956 |
March 20, 2024 | 0.99 |
March 19, 2024 | 0.96 |
March 18, 2024 | 1.10 |
March 15, 2024 | 1.15 |
March 14, 2024 | 1.14 |
March 13, 2024 | 1.17 |
March 12, 2024 | 1.18 |
March 11, 2024 | 1.24 |
March 08, 2024 | 1.26 |
March 07, 2024 | 1.26 |
March 06, 2024 | 1.25 |
March 05, 2024 | 1.21 |
March 04, 2024 | 1.18 |
March 01, 2024 | 1.17 |
February 29, 2024 | 1.15 |
February 28, 2024 | 1.24 |
February 27, 2024 | 1.205 |
February 26, 2024 | 1.19 |
February 23, 2024 | 1.18 |
February 22, 2024 | 1.18 |
Date | Value |
---|---|
February 21, 2024 | 1.19 |
February 20, 2024 | 1.22 |
February 16, 2024 | 1.15 |
February 15, 2024 | 1.04 |
February 14, 2024 | 1.05 |
February 13, 2024 | 1.03 |
February 12, 2024 | 1.05 |
February 09, 2024 | 0.93 |
February 08, 2024 | 0.9101 |
February 07, 2024 | 0.9179 |
February 06, 2024 | 0.929 |
February 05, 2024 | 0.9055 |
February 02, 2024 | 0.9315 |
February 01, 2024 | 0.9308 |
January 31, 2024 | 0.9364 |
January 30, 2024 | 0.9417 |
January 29, 2024 | 0.9131 |
January 26, 2024 | 0.9296 |
January 25, 2024 | 0.93 |
January 24, 2024 | 0.916 |
January 23, 2024 | 0.93 |
January 22, 2024 | 0.93 |
January 19, 2024 | 0.9245 |
January 18, 2024 | 0.9203 |
January 17, 2024 | 0.9401 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.9001
Minimum
Nov 13 2023
11.25
Maximum
Feb 17 2021
3.403
Average
2.38
Median
Sep 18 2019
Total Return Level Benchmarks
UFP Technologies Inc | 252.68 |
Dentsply Sirona Inc | 41.12 |
Arbutus Biopharma Corp | 2.59 |
Pacira BioSciences Inc | 29.03 |
Karyopharm Therapeutics Inc | 1.480 |